Good morning. Thank you for the invitation to attend this meeting.
My name is Bohdan Nosyk. I'm a professor and St. Paul's Hospital CANFAR chair in HIV/AIDS research at the faculty of health sciences at Simon Fraser University. I'm also senior author of a study evaluating B.C.'s risk mitigation guidance, what I'll call "RMG". It was later termed “prescribed safer supply”, and was published in the British Medical Journal in January 2024.
I'll focus my opening statement on this study, as I know it is of interest to this committee.
The study was conducted at a true provincial scale—